Saccharomyces cerevisiae

Saccharomyces cerevisiae
Mogana Das Murtey and Patchamuthu Ramasamy · CC BY 3.0 · source
Name	Saccharomyces cerevisiae
Regnum	Fungi
Phylum	Ascomycota
Classis	Saccharomycetes
Ordo	Saccharomycetales
Familia	Saccharomycetaceae
Genus	Saccharomyces
Species	S. cerevisiae

Contents

Saccharomyces cerevisiae is a unicellular ascomycete yeast widely used in baking, brewing, biotechnology, and basic research. Originating from fermentative traditions associated with ancient Mesopotamia, Ancient Egypt, and Indus Valley Civilization, it has become a central organism in modern biotechnology and molecular biology laboratories affiliated with institutions such as Harvard University, Massachusetts Institute of Technology, European Molecular Biology Laboratory, and Max Planck Society. Its tractability has linked it historically to figures and projects including Gregor Mendel, James Watson, Francis Crick, Antony van Leeuwenhoek, and the Human Genome Project.

Taxonomy and genetics

S. cerevisiae belongs to the kingdom Fungi within the phylum Ascomycota and the family Saccharomycetaceae, originally classified by taxonomists working alongside museums like the Natural History Museum, London and the Smithsonian Institution. Genome sequencing efforts led by consortia including the Saccharomyces Genome Database and teams at Whitehead Institute and University of Cambridge produced the first complete eukaryotic genome draft, a milestone comparable to projects at Wellcome Trust, European Research Council, and the National Institutes of Health. Its haploid genome comprises 16 chromosomes with canonical loci like those studied by researchers at Cold Spring Harbor Laboratory, Salk Institute, Broad Institute, and University of California, Berkeley. Genetic tools developed through collaborations with entities such as Genentech, Novartis, Pfizer, Amgen, and academic groups at University of Oxford allow gene deletion libraries, CRISPR-based edits from labs like Zhang Lab (Broad Institute), and synthetic chromosome projects coordinated by J. Craig Venter Institute and Synthetic Yeast Project participants.

Under microscopes in collections at Smithsonian Institution and teaching labs at Columbia University or Stanford University, it exhibits round to ovoid cells that bud asymmetrically, forming asci under sporulation conditions first characterized in studies at University of Vienna and University of Heidelberg. The life cycle alternates between haploid and diploid phases, mating types originally elucidated by geneticists affiliated with University of Chicago, University College London, and Yale University. Meiosis and sporulation signaling pathways intersect with cell-cycle regulators researched at Max Planck Institute for Molecular Genetics, Rockefeller University, and Institut Pasteur. Ultrastructural work undertaken at facilities like European Synchrotron Radiation Facility and Lawrence Berkeley National Laboratory has detailed cell wall, vacuole, and mitochondrial morphologies relevant to studies conducted by groups at Princeton University and Johns Hopkins University.

S. cerevisiae performs fermentative metabolism enabling ethanol production, a trait exploited by enterprises such as Heineken, Anheuser-Busch, and Diageo and studied in metabolic engineering programs at ETH Zurich, KAUST, and University of Tokyo. Core pathways—glycolysis, tricarboxylic acid cycle, oxidative phosphorylation, and the pentose phosphate pathway—were mapped by investigators from University of California, San Diego, University of Michigan, and Imperial College London. Respiration-versus-fermentation regulation involves the TOR, PKA, and SNF1 pathways characterized in labs at University of Cambridge, University of Edinburgh, and Institut Curie. Industrial strain optimization has involved collaborations with companies like Archer Daniels Midland, Novozymes, and Cargill and academic groups at North Carolina State University, University of Wisconsin–Madison, and Purdue University.

Wild and domesticated strains have been isolated from environments such as oak bark, fruit surfaces, and winery fermentations studied by researchers at University of California, Davis, Institut National de la Recherche Agronomique, and University of Porto. Biogeography work referencing collections from Galápagos Islands, Canary Islands, Mount Olympus, and Amazon rainforest highlights genetic diversity analyzed by teams at University of Barcelona, University of São Paulo, and National University of Singapore. Interactions with insects like Saccharomyces-associated Drosophila species and vectors observed in studies at University of Oxford (Zoology), Smithsonian Tropical Research Institute, and University of Copenhagen influence dispersal and fermentation ecology documented by ecologists at Columbia University and University of Texas at Austin.

S. cerevisiae underpins baking industries represented by companies like King Arthur Flour and Lesaffre and brewing operations including SABMiller and Molson Coors. It serves in production pipelines at biotech firms Amyris, Zymergen, and Ginkgo Bioworks for biofuels, commodity chemicals, and flavors, with scale-up performed in facilities by BASF and Dow Chemical. Synthetic biology projects from teams at MIT Media Lab, Harvard Wyss Institute, and University of California, Berkeley have engineered pathways for production of pharmaceuticals like artemisinin analogs echoing collaborations with Sanofi and Novartis. Fermentation technology integration involves partnerships with NASA for life-support experiments and with European Space Agency for space biotechnology evaluations.

As a premier eukaryotic model, it is central to teaching and research at universities including University of Cambridge, Oxford University, Harvard Medical School, and University of California, San Francisco. Discoveries in cell cycle control, first highlighted by work at University of California, San Diego and University of Basel, led to Nobel recognitions at institutions tied to laureates associated with Rockefeller University and Massachusetts Institute of Technology. Large-scale interaction maps and systems biology studies have been produced by consortia involving European Molecular Biology Laboratory, Broad Institute, and EMBL-EBI, with data curated in resources maintained by National Center for Biotechnology Information and the European Bioinformatics Institute. Yeast two-hybrid systems and expression platforms developed in labs at Stanford University and Cold Spring Harbor Laboratory continue to support proteomics and functional genomics projects at Sanger Institute and Wellcome Trust Centre for Human Genetics.

Generally regarded as nonpathogenic, it is classified as GRAS by regulatory bodies such as the United States Food and Drug Administration and regulated in clinical contexts by agencies like the European Medicines Agency and World Health Organization. Opportunistic infections have been reported in immunocompromised patients treated in hospitals affiliated with Mayo Clinic, Cleveland Clinic, and Johns Hopkins Hospital, prompting surveillance by Centers for Disease Control and Prevention and Public Health England. Laboratory biosafety guidelines from institutions including NIH, WHO, and OECD outline containment levels and handling procedures used across academia, industry, and clinical labs at University of Toronto and McGill University.